NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹811,693 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹41 Cr |
Mar2024 | ₹20 Cr |
Mar2023 | ₹50 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹811,693 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹41 Cr | 101.67 | |
Mar2024 | ₹20 Cr | -59.05 | |
Mar2023 | ₹50 Cr | -11.91 | |
Mar2022 | ₹57 Cr | -99.99 | |
Mar2021 | ₹811,693 Cr | - |
Compare Consolidated Net Profit of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹796.6 Cr | 5.5% | 4.3% | -49.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 5.5% |
4.3% |
-49.8% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses